Jennifer Doudna: How CRISPR lets us edit our DNA
Jennifer Doudna: Sada možemo uređivati DNA, ali učinimo to mudro
Jennifer Doudna was part of inventing a potentially world-changing genetic technology: the gene editing technology CRISPR-Cas9. Full bio
Double-click the English transcript below to play the video.
for editing genomes.
za uređivanje genoma.
scientists to make changes
znanstvenicima da mijenjaju
to cure genetic disease.
u liječenju genetskih bolesti.
through a basic research project
preko osnovnog istraživanja
how bacteria fight viral infections.
načina otpornosti bakterija na virusne infekcije.
in their environment,
u njihovom okolišu
like a ticking time bomb --
kao tempiranu bombu -
to defuse the bomb
detonirati bombu
an adaptive immune system called CRISPR,
adaptivni imunosustav koji se zove CRISPR,
viral DNA and destroy it.
virusni DNK i unište ga.
is a protein called Cas9,
protein koji se zove Cas9,
and eventually degrade viral DNA
na kraju i uništiti virusni DNK
of this protein, Cas9,
ovog proteina, Cas9,
harness its function
iskoristiti njegovu funkciju
specific bits of DNA into cells
specifične dijelove DNK u stanice
been possible in the past.
prije bile nemoguće.
has already been used
već se počela koristiti
of mice and monkeys,
miševa i majmuna,
nedavno otkrili
the CRISPR technology
CRISPR metodu
they could use CRISPR
koristili su CRISPR
of an integrated HIV virus
integriranog virusa HIV-a
of genome editing
uređivanja gena
that we have to consider,
koja trebamo razmotriti
not only in adult cells,
ne samo na odraslim stanicama,
about the technology that I co-invented,
o ovoj metodi koju smo izumile,
and societal implications
i društvene implikacije
what the CRISPR technology is,
opisati vam CRISPR,
a prudent path forward
razborito napredovati
they inject their DNA.
ubace svoj DNK.
to be plucked out of the virus,
izvadi iz virusne stanice,
into the chromosome --
u kromosom -
get inserted at a site called CRISPR.
umeću u dio koji se zove CRISPR.
interspaced short palindromic repeats.
kratke ponavljajuće palindromske sekvence.
we use the acronym CRISPR.
koristimo akronim CRISPR.
to record, over time,
mogu tijekom vremena bilježiti
are passed on to the cells' progeny,
prenose se na stanice potomke
not only in one generation,
ne samo u jednoj generaciji,
to keep a record of infection,
mogu zapamtiti neku infekciju,
Blake Wiedenheft, likes to say,
Blake Wiedenheft, voli reći,
a genetic vaccination card in cells.
za genetsko cijepljenje stanica.
into the bacterial chromosome,
u bakterijski kromosom,
of a molecule called RNA,
molekule koja se zove RNK,
of the viral DNA.
virusnog DNK.
with DNA molecules
između molekula DNK
from the CRISPR locus
na CRISPR sekvenci
to protein called Cas9,
protein koji se zove Cas9,
like a sentinel in the cell.
kao stražar u stanici.
of the DNA in the cell,
DNK u stanici
the sequences in the bound RNAs.
sekvence na vezanim RNK.
the blue molecule is DNA --
DNK je plava molekula -
to cut up the viral DNA.
da izreže virusni DNK.
sentinel complex
stražarski kompleks
that can cut DNA --
koji reže DNK -
in the DNA helix.
na uzvojnici DNK.
this complex is programmable,
ovaj je kompleks programabilan
particular DNA sequences,
određene sekvence DNK,
could be harnessed for genome engineering,
može iskoristiti za genetički inženjering,
a very precise change to the DNA
preciznu izmjenu vlastitog DNK
this break was introduced.
potrebna promjena.
a word-processing program
program za obradu teksta
the CRISPR system for genome engineering
CRISPR sustava za genetički inženjering
to detect broken DNA
otkriti oštećeni DNK
a double-stranded break in its DNA,
grešku na dvostrukom lancu DNK,
the ends of the broken DNA
krajeve slomljenog DNK
in the sequence of that position,
u sekvenci na tom mjestu
a new piece of DNA at the site of the cut.
novih sekvenci DNK na mjestu loma.
double-stranded breaks into DNA
dvolančane lomove na DNK
to repair those breaks,
na popravak tih lomova
of new genetic information.
nove genetske informacije.
the CRISPR technology
CRISPR metode
causing cystic fibrosis, for example,
uzrokuje, primjerice, cističnu fibrozu,
to repair that mutation.
na ispravak mutacije.
it's been in development since the 1970s.
u razvoju je od 1970-ih.
were very promising,
vrlo obećavajuće,
that they were either inefficient,
ili nedovoljno učinkovite
for use in their own laboratories,
za upotrebu u svojim laboratorijima,
clinical applications.
kliničke primjene.
like CRISPR and utilize it has appeal,
CRISPR upotrijebi je privlačna
genome engineering technologies
genetskog inženjeringa
to rewire your computer
vašeg računala
a new piece of software,
pokrenuti novi softver,
is like software for the genome,
kao stoftver za genom,
using these little bits of RNA.
korištenjem dijelića RNK.
break is made in DNA,
lom napravljen na DNK,
astounding things,
zapanjujuće stvari,
that cause sickle cell anemia
koje uzrokuje anemiju srpastih stanica
applications of the CRISPR technology
primjene CRISPR metode
to deliver this tool into cells,
koristiti ovu metodu na stanicama
that's going on
se sada odvija
of human disease, such as mice.
ljudskih bolesti, kao što su miševi.
very precise changes
vrlo precizne promjene
that these changes in the cell's DNA
na koji ove promjene u staničnom DNK
in this case, an entire organism.
slučaju, na cijeli organizam.
was used to disrupt a gene
poremetili gene
for the black coat color of these mice.
za crnu boju krzna ovog miša.
differ from their pigmented litter-mates
razlikuje od svojih obojanih sustanara
in the entire genome,
u cijelom genomu,
from these animals,
ovih životinja,
where we induced it,
na kojem smo ju inducirali
are going on in other animals
na drugim životinjama
for human disease,
za ljudske bolesti,
that we can use these systems
da ovakav sustav možemo koristiti
in particular tissues,
u određenim tkivima,
the CRISPR tool into cells.
CRISPR u stanice.
that DNA is repaired after it's cut,
na koji je DNK popravljen nakon reza,
and limit any kind of off-target,
i ograničiti bilo koji neciljan
of using the technology.
korištenja ove metode.
clinical application of this technology,
ovu metodu u kliničkoj uporabi,
that we will see clinical trials
da će postojati klinička ispitivanja,
therapies within that time,
terapije unutar tog vremena,
to think about.
kad razmislite.
around this technology,
oko ove metode,
in start-up companies
u novim tvrtkama
to commercialize the CRISPR technology,
kako bi komercijalizirale CRISPR metodu,
in these companies.
u ove tvrtke.
for things like enhancement.
za stvari kao što je poboljšanje.
to engineer humans
stvoriti ljude
such as stronger bones,
kao što su jače kosti,
to cardiovascular disease
kardiovaskularnim bolestima
to be desirable,
smatrali poželjnijima,
or to be taller, things like that.
ili visina, takve stvari.
would give rise to these traits
koji bi doveli do takvih osobina
to make such changes,
takvu vrstu promjene,
that we have to carefully consider,
koja je potrebno pomno razmotriti,
have called for a global pause
pozvali na globalnu stanku
of the CRISPR technology in human embryos,
CRISPR metode na ljudskim embrijima,
implications of doing so.
implikacije za to.
precedent for such a pause
presedan za takvu stanku
on the use of molecular cloning,
korištenje molekularnog kloniranja,
could be tested carefully and validated.
pažljivo ne testira i opravda.
are not with us yet,
još ne postoje,
are happening right now.
sada su stvarnost.
a huge responsibility,
veliku odgovornost
both the unintended consequences
neželjene posljedice
of a scientific breakthrough.
ovog znanstvenog otkrića.
a technology with huge consequences,
metoda koja nosi velike posljedice,
or a moratorium or a quarantine
ili moratorijem ili karantenom
the therapeutic results of this,
terapijski rezultati ovoga,
gaining traction,
najviše pažnje,
of The Economist -- "Editing humanity."
The Economista – „Uređivanje čovječanstva“
it's not about therapeutics.
a ne o liječenju.
did you get back in March
dobili u ožujku
for a moment and think about it?
na trenutak i razmisliti o svemu?
were actually, I think, delighted
zapravo bili oduševljeni
to discuss this openly.
otvoreno razgovarati.
as well as others,
ali i drugima,
of viewpoints about this.
pogledi na sve ovo.
careful consideration and discussion.
pažljivo razmatranje i rasprava.
happening in December
u prosincu ove godine
of Sciences and others,
znanosti i drugima,
out of the meeting, practically?
proizaći iz njega?
and stakeholders
i dioničara
this technology responsibly.
metodu odgovorno upotrebljavati.
a consensus point of view,
zajedničkog stajališta,
for example, at Harvard,
s Harvada, primjerice,
are just a question of safety.
pitanja sigurnosti.
in animals and in labs,
na životinjama i u laboratoriju,
we move on to humans."
prijeći ćemo na ljude.“
school of thought,
način razmišljanja,
this opportunity and really go for it.
u potpunosti iskoristiti.
in the science community about this?
imati podijeljena mišljenja o ovome?
some people holding back
neke ljude kako se suzdržavaju
or don't regulate at all?
ne reguliraju etička pitanja?
especially something like this,
a posebno nekom kao što je ova,
a variety of viewpoints,
različita stajališta,
perfectly understandable.
sasvim razumljivo.
for human genome engineering,
za genomski inženjering ljudi,
consideration and discussion
razmatranja i rasprave
and other fields of science
i druga znanstvena polja
pretty much like yours.
slično kao i vaše.
intelligence, autonomous robots and so on.
samoupravljajućim robotima i tako dalje.
a similar discussion in those fields,
sličnu raspravu na tim poljima,
serve as a blueprint for other fields?
poslužiti kao predložak za ostala polja?
to get out of the laboratory.
teško napustiti laboratorij.
uncomfortable to do that.
in the genesis of this
u nastanak ovoga
in a position of responsibility.
na odgovornu poziciju.
that other technologies
da će ostale metode
something that could have implications
nešto što bi moglo imati implikacije
ABOUT THE SPEAKER
Jennifer Doudna - BiologistJennifer Doudna was part of inventing a potentially world-changing genetic technology: the gene editing technology CRISPR-Cas9.
Why you should listen
Together with her colleague Emmanuelle Charpentier of Umeå University in Sweden, Berkeley biologist Jennifer Doudna is at the center of one of today's most-discussed science discoveries: a technology called CRISPR-Cas9 that allows human genome editing by adding or removing genetic material at will. This enables fighting genetic diseases (cutting out HIV, altering cancer cells) as well as, potentially, opening the road to "engineered humans."
Because some applications of genetic manipulation can be inherited, Doudna and numerous colleagues have called for prudent use of the technology until the ethics and safety have been properly considered.
Doudna is the co-winner of the 2018 Kavli Prize in Nanoscience, along with Emmanuelle Charpentier and Virginijus Šikšnys.
Jennifer Doudna | Speaker | TED.com